Susan Harvey to Receptor, ErbB-2
This is a "connection" page, showing publications Susan Harvey has written about Receptor, ErbB-2.
Connection Strength
0.030
-
Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions. Oncology (Williston Park). 2015 Nov; 29(11):828-38.
Score: 0.030